Study of radiation with a new drug for cancer spread to the brain lining
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new radioactive drug (called REYOBIQ) that is given directly into the fluid around the brain, along with either whole-brain radiation or a more targeted type of radiation, to treat cancer that has spread to the lining of the brain. The goal is to see if this combination is safe and helps control the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old.
- Have cancer that has spread to the lining of the brain or spinal cord, confirmed by a spinal tap test.
- Be able to care for yourself (score of 60 or higher on a daily activity scale).
- Have acceptable liver, kidney, and blood test results.
- Have not had whole-brain radiation in the past.
- Do not have a shunt or other condition that prevents placement of a small reservoir under the scalp.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two cancer drugs given together (one into the spinal fluid, one through a vein) to treat leptomeningeal metastasis, which is cancer that has spread to the lining of the brain or spinal cord. The goal is to see if this combination can control the cancer and improve symptoms.
This trial tests a radioactive nanoparticle drug given directly into the fluid around the brain and spine to treat cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastases). It aims to see if this targeted treatment is safe and might help shrink or control the cancer.
This trial tests whether a precise type of radiation to the brain and spine (craniospinal irradiation) can help control cancer that has spread to the lining of the brain and spinal cord (leptomeningeal disease) in people with breast cancer or non-small cell lung cancer. The goal is to improve symptoms and slow disease progression.
This trial tests proton radiation to treat cancer that has spread into the thin lining around the brain and/or spinal cord (leptomeningeal metastasis). It may help control disease in that area while aiming to better protect surrounding healthy tissue.
This trial tests a new drug, NBQ72S, for people with breast cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastasis). It aims to see if the drug is safe and helpful for these patients.
This trial tests a special type of radiation that avoids the memory center of the brain (the hippocampus) while treating cancer that has spread to the lining of the brain and spinal cord. It may help reduce side effects on thinking and memory for people with breast or lung cancer.
Hear when a new Leptomeningeal Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.